Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


S. Korea FDA Faults Seven Designated Imported-Drugs Inspectors

This article was originally published in PharmAsia News

Executive Summary

South Korea's FDA says it has taken action against seven private institutes it relies on to check imported medical goods for harmful ingredients or metals. One of the institutes was removed from KFDA's list of designated agencies and another six were told to correct mistakes. KFDA and the Health Ministry inspected the agencies and found the seven failed to follow procedures and proper methods when inspecting herbal materials. In some cases the agencies failed to carry out inspections. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts